Collegium Pharmaceutical, Inc. (COLL) — Fair Value Analysis

Base-case fair value (P50): $37.24 · Current price: $37.03 · Verdict: Fairly Valued

The Verdict on COLL

COLLEGIUM PHARMACEUTICAL INC (COLL) is currently assessed as Fairly Valued based on our latest Monte Carlo simulations. With a current price of $37.03, COLL sits just below its median fair value (P50) of $37.24. This indicates an +0.6% upside, suggesting the market price closely aligns with the intrinsic value derived from thousands of forward-looking scenarios. Our analysis, which rigorously models future financial outcomes, concludes that COLL is trading near its equilibrium point, offering limited immediate arbitrage opportunities based purely on this median valuation.

How COLL stacks up against peers

While COLLEGIUM PHARMACEUTICAL INC (COLL) operates in a dynamic market, its quality tier regarding operational and financial health versus its sector is currently unrated. Despite this unrated status for comparative health metrics, our Monte Carlo valuation remains robust, focusing directly on COLL's specific financial projections. The fair value assessment, indicating $37.03 is very close to $37.24, is a function of COLL's standalone financial outlook, independent of a formal peer quality tiering. Investors should note this unrated status when considering broader sector comparisons, though it doesn't invalidate the individual fair value calculation.

What this means for investors

For investors, COLL's Fairly Valued status, with its $37.03 closely tracking the $37.24 and an +0.6% marginal upside, suggests that current prices largely reflect the company's intrinsic value based on our comprehensive simulations. While the P50 indicates balance, the full Monte Carlo distribution offers a broader perspective, including potential bear and bull case scenarios. Accessing the full probabilistic range and understanding the likelihood of various outcomes is crucial for informed decision-making. Sign up for a free FairCurve account to see COLL's full bear and bull distribution and track its fair value as new fundamentals are released.